Top Gainers - Stock Screener (2024)

OverviewValuationFinancialOwnershipPerformanceTechnicalETFETF PerfCustomChartsTickersBasicTANewsSnapshotMapsStats
Top Gainers - Stock Screener (1)

#1 / 200 Total

Type:

TA:on|off

Refresh: 3min | off

Top Gainers - Stock Screener (2)
TickerAPM [NASD]
CompanyAptorum Group Ltd
CountryUnited Kingdom
IndustryBiotechnology
Market Cap49.16MEPS (ttm)-3.64
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-26.55%
P/S40.97EPS next 5Y-
P/B2.25EPS Q/Q-169.81%
Dividend-Sales Q/Q-18.22%
Insider Own51.38%Inst Own0.85%
Insider Trans0.00%Inst Trans445.84%
Short Float0.15%EarningsDec 22/a
Analyst Recom1.00Target Price80.00
Avg Volume1.39M52W Range1.35 - 17.49

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.

Top Gainers - Stock Screener (4)
TickerPHGE [AMEX]
CompanyBiomX Inc
CountryIsrael
IndustryBiotechnology
Market Cap31.63MEPS (ttm)-0.65
P/E-EPS this Y43.16%
Forward P/E-EPS next Y34.26%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.88EPS Q/Q42.43%
Dividend-Sales Q/Q-
Insider Own45.46%Inst Own0.77%
Insider Trans-0.05%Inst Trans-0.19%
Short Float0.38%EarningsNov 14/b
Analyst Recom1.00Target Price5.50
Avg Volume2.46M52W Range0.19 - 0.86
Mar-06-24 07:30AM BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing (GlobeNewswire) +197.66%
Jan-04-24 08:00AM BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis (GlobeNewswire)
Nov-30-23 04:15PM BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023 (GlobeNewswire) -13.67%
Nov-29-23 06:30AM BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis (GlobeNewswire) -46.43%
Nov-14-23 06:30AM BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Oct-27-23 08:00AM BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference (GlobeNewswire)
Oct-18-23 08:00AM BiomX Announces the Appointment of Edward L. Williams to its Board of Directors (GlobeNewswire)
Oct-04-23 06:34AM BiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis (GlobeNewswire)
Sep-07-23 09:00AM BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023 (GlobeNewswire)
Sep-06-23 04:05PM BiomX to Present at H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)

BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage co*cktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.

Insider TradingRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Oron AssafChief Business OfficerNov 29 '23Sale0.3710,9144,0720Dec 01 04:46 PM
Oron AssafChief Business OfficerMay 22 '23Buy0.273,19287210,914May 24 06:03 AM
Oron AssafChief Business OfficerMay 19 '23Buy0.286,5211,8327,722May 22 04:01 PM
Oron AssafChief Business OfficerMay 18 '23Buy0.271,2013281,201May 22 04:01 PM
Top Gainers - Stock Screener (6)
TickerSWIN [NASD]
CompanySolowin Holdings
CountryHong Kong
IndustryCapital Markets
Market Cap658.00MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own82.76%Inst Own0.01%
Insider Trans0.00%Inst Trans-
Short Float6.26%Earnings-
Analyst Recom-Target Price-
Avg Volume205.88K52W Range1.84 - 65.94

Solowin Holdings engages in the provision of securities brokerage solutions through its subsidiary. It operates through the following segments: Securities Related Services, Investment Advisory Services, Asset Management Services, and Corporate. The Securities Related Services segment is involved in offering securities dealing and brokerage services, securities underwriting and placing services, and other financing services. The Investment Advisory Services segment offers investment solutions advisory services for clients, through a team consists of financial analysts, financial advisors, and investment managers. The Asset Management Services segment specializes in designing investment portfolios for investors with different risk appetite and to preserve the value of assets. The company was founded on July 23, 2021 and is headquartered in Hong Kong.

Top Gainers - Stock Screener (8)
TickerNKGN [NASD]
CompanyNKGen Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap40.06MEPS (ttm)-2.71
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-6081.40%
Dividend-Sales Q/Q-
Insider Own60.46%Inst Own14.84%
Insider Trans0.01%Inst Trans14.78%
Short Float3.83%Earnings-
Analyst Recom-Target Price-
Avg Volume1.85M52W Range0.78 - 12.88
Mar-06-24 07:52AM Why Is NKGen Biotech (NKGN) Stock Up 62% Today? (InvestorPlace) +112.30%
Mar-04-24 08:00AM NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer's Disease at the Tau2024 Global Conference (GlobeNewswire)
Feb-07-24 08:57AM Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies (News Direct)
Dec-29-23 07:30AM NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial (News Direct) -10.42%
Dec-28-23 04:05PM NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer's Disease (GlobeNewswire) -7.53%
Dec-27-23 08:00AM NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer's Disease (GlobeNewswire) +17.73%
Nov-14-23 04:48PM NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
Oct-26-23 08:00AM NKGen Biotech Presented Phase I Clinical Trial Data at the 16th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference (GlobeNewswire) +8.00%
Oct-24-23 10:53AM NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimers Disease Treatment. (News Direct) +16.16%
08:00AM NKGen Biotech Announces FDA Clearance of Investigational New Drug Application for SNK01 NK Cell Therapyto Treat Alzheimers Disease (GlobeNewswire)

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company is headquartered in Santa Ana, CA.

Insider TradingRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Song Paul Y.Chief Executive OfficerDec 07 '23Buy3.2976250171,121Dec 07 05:23 PM
Song Paul Y.Chief Executive OfficerDec 06 '23Buy3.3275250171,045Dec 07 05:23 PM
Song Paul Y.Chief Executive OfficerDec 05 '23Buy3.33105350170,969Dec 05 03:51 PM
Graf James AInterim CFODec 04 '23Buy3.194501,436693Dec 05 03:50 PM
Song Paul Y.Chief Executive OfficerDec 04 '23Buy3.07163500170,864Dec 05 03:51 PM
Top Gainers - Stock Screener (10)
TickerMEDS [NASD]
CompanyTrxade Health Inc
CountryUSA
IndustryPharmaceutical Retailers
Market Cap20.88MEPS (ttm)-9.97
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.30EPS next 5Y-
P/B1.22EPS Q/Q-399.78%
Dividend-Sales Q/Q-14.26%
Insider Own29.56%Inst Own5.66%
Insider Trans0.00%Inst Trans-3.86%
Short Float1.34%Earnings-
Analyst Recom1.00Target Price6.75
Avg Volume387.22K52W Range3.69 - 21.22

TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. It operates through the following segments: Trxade, Inc., CSP, Integra, and Other. The Trxade, Inc. segment is involved in web based pharmaceutical marketplace platform B2B sales. The CSP segment refers to community specialty pharmacy, LLC - Licensed retail pharmacy B2C sales. The Integra segment consists of Integra Pharma, LLC, Licensed wholesaler of brand, generic and non-drug products B2B sales. The Other segment consists of corporate overhead expense, Alliance Pharma Solutions, LLC, and Bonum Health, LLC. The company was founded by Suren Ajjarapu and Prashant Patel on July 15, 2005 and is headquartered in Lutz, FL.

Top Gainers - Stock Screener (12)
TickerHOVR [NASD]
CompanyNew Horizon Aircraft Ltd
CountryCanada
Industry
Market Cap-EPS (ttm)0.16
P/E14.39EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.36EPS Q/Q6700.00%
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.16%Earnings-
Analyst Recom-Target Price-
Avg Volume189.76K52W Range1.00 - 12.14

New Horizon Aircraft Ltd. is an advanced aerospace original equipment manufacturer, which engages in the designing and aiming to build a next generation hybrid electric vertical takeoff and landing aircraft for the regional air mobility market. The company was founded on March 11, 2022 and is headquartered in Lindsay, Canada.

Top Gainers - Stock Screener (14)
TickerRVSN [NASD]
CompanyRail Vision Ltd
CountryIsrael
IndustryRailroads
Market Cap9.45MEPS (ttm)-4.86
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-63.85%
P/S67.50EPS next 5Y-
P/B1.50EPS Q/Q33.28%
Dividend-Sales Q/Q-29.70%
Insider Own45.24%Inst Own1.57%
Insider Trans0.00%Inst Trans-
Short Float14.20%EarningsNov 24/b
Analyst Recom1.00Target Price56.00
Avg Volume7.06M52W Range1.01 - 23.37

Rail Vision Ltd. engages in the design, development, and manufacture of a technology that focuses on cognitive vision and safety system for the railway industry. It operates through the following segments: Locomotives for Shunting Yards, Locomotives for Passenger and Freight Trains, and Light Rail Vehicle. The Locomotives for Shunting Yards segment focuses on the sale of RV200 system to shunting yard operators. The Locomotives for Passenger and Freight Trains segment promotes sales to passenger and freight train operators. The Light Rail Vehicle segment are in the process of developing an LRV system that will be designed for the light rail market segment. The company was founded by Elen Katz, Shahar Hania, Noam Teich, and Yuval Isbi in 2015 and is headquartered in Ra'anana, Israel.

Top Gainers - Stock Screener (16)
TickerHCMA [NASD]
CompanyHcm Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap74.83MEPS (ttm)0.09
P/E82.13EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.07EPS Q/Q-238.88%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own40.19%
Insider Trans-Inst Trans12.12%
Short Float0.00%Earnings-
Analyst Recom-Target Price-
Avg Volume76.86K52W Range3.60 - 11.50

HCM Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to identify businesses, which provide disruptive technology or innovations within the financial services industry. The company was founded on February 5, 2021 and is headquartered in Stamford, CT.

Top Gainers - Stock Screener (18)
TickerIFBD [NASD]
CompanyInfobird Co Ltd
CountryChina
IndustrySoftware - Application
Market Cap10.22MEPS (ttm)-6.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.49EPS next 5Y-
P/B5.61EPS Q/Q97.28%
Dividend-Sales Q/Q-100.00%
Insider Own-Inst Own0.23%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price9976.00
Avg Volume511.07K52W Range3.44 - 576.00

Infobird Co. Ltd. engages in the provision of standard and customized customer relationship management cloud-based services. It offers software-as-a-service (SaaS) and business process outsourcing (BPO) services to clients, through its variable interest entity. The company was founded in 2001 and is headquartered in Beijing, China.

Top Gainers - Stock Screener (20)
TickerPWM [NASD]
CompanyPrestige Wealth Inc
CountryHong Kong
IndustryAsset Management
Market Cap14.94MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.29%
Insider Trans-Inst Trans-
Short Float0.81%Earnings-
Analyst Recom-Target Price-
Avg Volume135.24K52W Range1.15 - 31.88

Prestige Wealth, Inc. engages in providing wealth management and asset management services. Through its subsidiaries, the firm assist its clients in identifying and purchasing well matched wealth management products and global asset management products. The company was founded by Chi Tak Sze on October 25, 2018 and is headquartered in Hong Kong.

Top Gainers - Stock Screener (22)
1234561020
Top Gainers - Stock Screener (23)
Top Gainers - Stock Screener (2024)

FAQs

What is the most successful stock screener? ›

  • 9 Best Stock Screeners of 2024. TIKR. Finchat. Finviz. TradingView. YCharts. Yahoo Finance. Zacks. Seeking Alpha.
  • FAQ.
Mar 6, 2024

Who is the most accurate stock predictor? ›

1. AltIndex – Overall Most Accurate Stock Predictor with Claimed 72% Win Rate. From our research, AltIndex is the most accurate stock predictor to consider today. Unlike other predictor services, AltIndex doesn't rely on manual research or analysis.

How to predict top gainers stock? ›

Top Gainers are calculated by finding the percentage increase of the price of shares on a single market day from its opening price. The shares that have gained the most, in terms of that percentage, are the Top Gainers. The Top Gainers and Top Losers are both representative of the market direction and its trends.

What is the best website to filter stocks? ›

Ticker is the best free stock screener among all the others available. Most screeners available either charge for the services or, even if free, do not provide as much information necessary. Ticker has more than 1200 ratios that an investor can choose from, to filter out the stocks.

Who gives the best stock advice for free? ›

1. Motley Fool Stock Advisor: Best stock picking newsletter overall. Stock Advisor is The Motley Fool's flagship product and one of the most popular investing newsletters in the world with more than 500,000 subscribers. These subscribers are after one thing: High-quality stock picks.

Who is the best stock picker of all time? ›

Warren Buffett is one of the greatest investors of all time. Berkshire Hathaway, the company he's managed since 1965, has returned 19.8 percent annually through the end of 2023 during Buffett's leadership, nearly doubling the return of the S&P 500 on an annualized basis over that time period.

Which trading indicator has the highest accuracy? ›

Which is one of the most accurate trading indicators? The most accurate for trading is the Relative Strength Index. It is considered one of the best momentum indicators for intraday trading. It helps investors identify the shares which are bought and sold in the market.

What is the best AI to predict stocks? ›

Comparison
S. No.Tool NameUses
1EquBotAnalyze, Strategize
2Trade IdeasScan, Identify
3TrendSpiderChart, Analyze
4TradierTrade, Connect
6 more rows
Feb 22, 2024

What is the top gainer strategy? ›

Top gainers are arranged in descending order from top gainer to least gainer. Top losers are arranged in ascending order from top loser to least loser. In this context, top gainers resemble the rise in price for stocks. However, the concept of top gainers is also applicable to the cryptocurrency market.

What is Zacks Ultimate? ›

Our unique Zacks Ultimate program gives you full 30-day access to Zacks' market insights and the most private picks from ALL of our portfolio recommendation services for only $1.

Which stock will be top gainers today? ›

200 Companies under Top Gainers
CompanypriceRs.Change%
Bhilwara Technl.Text49.24+9.98%
BSL195.00+9.98%
ETT32.10+9.97%
Essar Shipping30.50+9.91%
156 more rows

Who is the most accurate stock picker? ›

Let's jump in!
  • Best overall: Motley Fool Stock Advisor. ...
  • Best quant-driven service: Alpha Picks. ...
  • Best for portfolio management: The Barbell Investor. ...
  • Best for a high-caliber team of analysts: Moby. ...
  • Best for disruptive technology: Motley Fool Rule Breakers. ...
  • Best for long-term swing trades: Ticker Nerd.
Mar 18, 2024

What is the best free stock screener? ›

6 best free stock screeners
  1. Morningstar. Morningstar's basic stock screener offers a clean interface with multiple filter options. ...
  2. Finviz. Finviz is often included in roundups of the best stock screeners, and for good reason. ...
  3. 3. Yahoo Finance. ...
  4. TradingView. ...
  5. StockFetcher.
Apr 29, 2024

Is Zacks reliable? ›

Zacks is a good fit for people who are relatively savvy — active investors but aren't yet ready to go it entirely alone and might want a little hand-holding and/or a backup plan for their online trades.

What is the most accurate indicator of what a stock is actually worth? ›

The price-to-earnings ratio (P/E ratio) is a metric that helps investors determine the market value of a stock compared to the company's earnings.

Who is the most successful stock analyst? ›

Mark Lipacis ranks No.
  • out of the 8,371 analysts tracked on TipRanks. The five-star analyst has an overall success rate of 73%. Lipacis' best rating has been on chipmaker Nvidia (NASDAQ:NVDA). ...
  • Jason Seidl - TD Cowen. Jason Seidl is second on the list and has a success rate of 73%. ...
  • Quinn Bolton - Needham.
Apr 23, 2023

What is the most accurate stock prediction algorithm? ›

The LSTM algorithm has the ability to store historical information and is widely used in stock price prediction (Heaton et al. 2016). For stock price prediction, LSTM network performance has been greatly appreciated when combined with NLP, which uses news text data as input to predict price trends.

Top Articles
Latest Posts
Article information

Author: Edwin Metz

Last Updated:

Views: 6268

Rating: 4.8 / 5 (58 voted)

Reviews: 89% of readers found this page helpful

Author information

Name: Edwin Metz

Birthday: 1997-04-16

Address: 51593 Leanne Light, Kuphalmouth, DE 50012-5183

Phone: +639107620957

Job: Corporate Banking Technician

Hobby: Reading, scrapbook, role-playing games, Fishing, Fishing, Scuba diving, Beekeeping

Introduction: My name is Edwin Metz, I am a fair, energetic, helpful, brave, outstanding, nice, helpful person who loves writing and wants to share my knowledge and understanding with you.